When.com Web Search

  1. Ads

    related to: approved biosimilars in the us list

Search results

  1. Results From The WOW.Com Content Network
  2. Biosimilar - Wikipedia

    en.wikipedia.org/wiki/Biosimilar

    As of October 2024, the US FDA has approved 60 biosimilars. [132] [133] BPCI Act

  3. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

  4. AscellaHealth Releases Q3 2024 Specialty & Rare Pipeline ...

    lite.aol.com/tech/story/0022/20241022/9259365.htm

    According to the data, FDA-approved biosimilars increased from 47 in Q1 to 60 by Q3, providing additional choices for more affordable healthcare treatment options. The rise in interchangeable biosimilars, from 8 to 14, emphasizes the value of biologics that can be substituted at the pharmacy, where state laws permit, for the reference product ...

  5. List of estrogens available in the United States - Wikipedia

    en.wikipedia.org/wiki/List_of_estrogens...

    This is a complete list of estrogens and formulations that are approved by the FDA Tooltip Food and Drug Administration and available in the United States. Estrogens are used as hormonal contraceptives, in hormone replacement therapy, and in the treatment of gynecological disorders.

  6. US FDA approves two biosimilars for blockbuster eye drug Eylea

    www.aol.com/news/us-fda-approves-two-biosimilars...

    The agency approved Biocon Biologics' Yesafili as well as Samsung Bioepis and Biogen's Opuviz, while also allowing interchangeability, or the drug's substitution with biosimilars without the need ...

  7. US FDA approves Amgen's biosimilar to AstraZeneca's rare ...

    www.aol.com/news/us-fda-approves-amgens...

    Amgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex biological drugs. In 2022, the company said that Bkemv met the main goal of a late stage study, where ...

  8. Adalimumab - Wikipedia

    en.wikipedia.org/wiki/Adalimumab

    In November 2019, adalimumab-afzb (Abrilada) was approved in the United States. [5] [103] [118] [119] [120] It is the 25th biosimilar approved by the FDA. [121] In February 2020, the biosimilar Amsparity was approved for use in the European Union. [13] In June 2020, the biosimilar Idacio was approved for use in Australia. [37]

  9. US FDA proposes to remove switching study requirement for ...

    www.aol.com/news/us-fda-proposes-remove...

    US FDA proposes to remove switching study requirement for biosimilars. June 20, 2024 at 12:06 PM (Reuters) - The U.S. Food and Drug Administration has proposed that biosimilar drugs seeking agency ...